Literature DB >> 9212783

Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin.

B Nerli1, D Romanini, G Picó.   

Abstract

The binding of some cephalosporins of pharmacological interest, to human serum albumin was studied using ultrafiltration method. The identification of the binding sites in albumin was also performed using probes for the so-called sites I, II, bilirubin and fatty acids binding sites. Cephalosporins were classified into three groups according to their affinity for albumin: low affinity (K = 10-10(2) M-1), medium affinity (K = 10(3) M-1) and high affinity (K = 10(4) M-1). Cephalosporin binding to albumin produced a perturbation of several basic amino acids of the protein such as histidine and lysine. It was found that only cefuroxime, ceftazidime and cefoperazone interact slightly with site I on serum albumin, while site II possesses capacity to bind: cephradine, cephalexin, ceftazidime, ceftriaxone, cefoperazone, cefaclor and cefsulodin. The bilirubin binding site showed capacity to interact with a great number of cephalosporins: ceftriaxone, cefazolin, cephaloglycin, cefamandole, cefotaxime, cefoxitin, cefuroxime, cefoperazone and cefadroxil. Ceftriaxone showed capacity to bind to the fatty acid binding site on HSA. No relation was found between the displacement of the marker and the chemical nature of the substituents at R1 and R2. Cephalosporins interact with HSA at the binding region that involves: tyrosyl 411, histidyl 146 and lysyls 195, 199, 225, 240 and 525 residues. The chemical modification of specific amino acids showed that the interaction of these amino acids with beta lactam antibiotics is not carried out to the same extent for all the cephalosporins tested. The results obtained revealed that the binding sites for cephalosporins on albumin are structurally heterogeneous, having different amino acids in the vicinity of the ligand molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212783     DOI: 10.1016/s0009-2797(97)00024-0

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  The participation of human serum albumin domains in chemical and thermal unfolding.

Authors:  B Farruggia; F Rodriguez; R Rigatuso; G Fidelio; G Picó
Journal:  J Protein Chem       Date:  2001-01

2.  Protein binding of cefazolin is saturable in vivo both between and within patients.

Authors:  Jane W A Vella-Brincat; Evan J Begg; Carl M J Kirkpatrick; Mei Zhang; Stephen T Chambers; Kate Gallagher
Journal:  Br J Clin Pharmacol       Date:  2007-01-12       Impact factor: 4.335

3.  Screening a fragment cocktail library using ultrafiltration.

Authors:  Sayaka Shibata; Zhongsheng Zhang; Konstantin V Korotkov; Jaclyn Delarosa; Alberto Napuli; Angela M Kelley; Natasha Mueller; Jennifer Ross; Frank H Zucker; Frederick S Buckner; Ethan A Merritt; Christophe L M J Verlinde; Wesley C Van Voorhis; Wim G J Hol; Erkang Fan
Journal:  Anal Bioanal Chem       Date:  2011-07-13       Impact factor: 4.142

4.  Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen.

Authors:  E Tsivou; I Melakopoulos; A Kotsiou; S Anagnostopoulou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

5.  Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.

Authors:  Michael Schleibinger; Cathérine L Steinbach; Christoph Töpper; Alexander Kratzer; Uwe Liebchen; Frieder Kees; Bernd Salzberger; Martin G Kees
Journal:  Br J Clin Pharmacol       Date:  2015-06-11       Impact factor: 4.335

6.  Cefazolin plasma protein binding and its covariates in neonates.

Authors:  A Smits; A Kulo; R Verbesselt; G Naulaers; J de Hoon; P Vermeersch; K Allegaert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-26       Impact factor: 3.267

7.  Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.

Authors:  Nathan E Basken; Carla J Mathias; Mark A Green
Journal:  J Pharm Sci       Date:  2009-06       Impact factor: 3.534

8.  Interactions of cephalexin with bovine serum albumin: displacement reaction and molecular docking.

Authors:  Hamed Hamishehkar; Soheila Hosseini; Abdolhossein Naseri; Azam Safarnejad; Farzaneh Rasoulzadeh
Journal:  Bioimpacts       Date:  2016-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.